Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuel Della-Torre

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Frontiers in Pharmacology|January 14, 2021
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the PandemicGiulio Cavalli, Nicola Farina, Corrado Campochiaro, et al.
Nature Reviews. Rheumatology|April 8, 2025
IgG4-related disease and other fibro-inflammatory conditionsFrancesco Peyronel, Emanuel Della-Torre, Federica Maritati, et al.
Autoimmunity Reviews|December 9, 2024
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel diseaseSarah Bencardino, Cosimo Simone Matichecchia, Jacopo Fanizza, et al.
Expert Review of Clinical Immunology|March 10, 2021
Emerging therapy options for IgG4-related diseaseMarco Lanzillotta, Andreu Fernàndez-Codina, Emma Culver, et al.
Rheumatology (Oxford, England)|June 26, 2025
Association of IgG4-related disease with human inborn errors of immunityBatani Veronica, Elisa Benetti, Claudia Minici, et al.
European Journal of Internal Medicine|January 2, 2021
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort studyEmanuel Della-Torre, Marco Lanzillotta, Corrado Campochiaro, et al.
Seminars in Arthritis and Rheumatism|June 18, 2021
Utility of the "2019 ACR/EULAR classification criteria" for the management of patients with IgG4-related diseaseEmanuel Della-Torre, Marco Lanzillotta, Tommaso Germanò, et al.
Rheumatology (Oxford, England)|June 28, 2020
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomesMarco Lanzillotta, Corrado Campochiaro, Gaia Mancuso, et al.
Seminars in Arthritis and Rheumatism|September 3, 2016
Juxta-vertebral lesions in granulomatosis with polyangiitisGiuseppe A Ramirez, Emanuel Della-Torre, Corrado Campochiaro, et al.
Endoscopic Ultrasound|February 10, 2022
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept studyMatteo Tacelli, Piera Zaccari, Maria Chiara Petrone, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|January 14, 2021
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the PandemicGiulio Cavalli, Nicola Farina, Corrado Campochiaro, et al.
Nature Reviews. Rheumatology|April 8, 2025
IgG4-related disease and other fibro-inflammatory conditionsFrancesco Peyronel, Emanuel Della-Torre, Federica Maritati, et al.
Autoimmunity Reviews|December 9, 2024
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel diseaseSarah Bencardino, Cosimo Simone Matichecchia, Jacopo Fanizza, et al.
Expert Review of Clinical Immunology|March 10, 2021
Emerging therapy options for IgG4-related diseaseMarco Lanzillotta, Andreu Fernàndez-Codina, Emma Culver, et al.
Rheumatology (Oxford, England)|June 26, 2025
Association of IgG4-related disease with human inborn errors of immunityBatani Veronica, Elisa Benetti, Claudia Minici, et al.
European Journal of Internal Medicine|January 2, 2021
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort studyEmanuel Della-Torre, Marco Lanzillotta, Corrado Campochiaro, et al.
Seminars in Arthritis and Rheumatism|June 18, 2021
Utility of the "2019 ACR/EULAR classification criteria" for the management of patients with IgG4-related diseaseEmanuel Della-Torre, Marco Lanzillotta, Tommaso Germanò, et al.
Rheumatology (Oxford, England)|June 28, 2020
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomesMarco Lanzillotta, Corrado Campochiaro, Gaia Mancuso, et al.
Seminars in Arthritis and Rheumatism|September 3, 2016
Juxta-vertebral lesions in granulomatosis with polyangiitisGiuseppe A Ramirez, Emanuel Della-Torre, Corrado Campochiaro, et al.
Endoscopic Ultrasound|February 10, 2022
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept studyMatteo Tacelli, Piera Zaccari, Maria Chiara Petrone, et al.
Pageof 9